RSL3
CAS: 1219810-16-8
Ref. 3D-UYB81016
| 1g | Discontinued | ||
| 2g | Discontinued | ||
| 5g | Discontinued | ||
| 10g | Discontinued | ||
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued | ||
| 500mg | Discontinued |
Product Information
Name:
RSL3
Description:
RSL3 is a small molecule drug that induces tumor cell death by activating the mitochondrial pathway of apoptosis. It also induces ferroptosis, which is a form of non-apoptotic cell death. RSL3 has been shown to induce autophagy in cells and cancer tissues, as well as regulate transcriptional activity. This compound has been shown to be an effective treatment for squamous carcinoma, and has also been shown to have anti-inflammatory properties.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
440.88 g/mol
Formula:
C23H21ClN2O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
